These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 17449759)
1. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759 [TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179 [TBL] [Abstract][Full Text] [Related]
3. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671 [TBL] [Abstract][Full Text] [Related]
5. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Christante D; Pommier S; Givi B; Pommier R Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993 [TBL] [Abstract][Full Text] [Related]
6. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Yao KA; Talamonti MS; Nemcek A; Angelos P; Chrisman H; Skarda J; Benson AB; Rao S; Joehl RJ Surgery; 2001 Oct; 130(4):677-82; discussion 682-5. PubMed ID: 11602899 [TBL] [Abstract][Full Text] [Related]
7. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases. Hur S; Chung JW; Kim HC; Oh DY; Lee SH; Bang YJ; Kim WH J Vasc Interv Radiol; 2013 Jul; 24(7):947-56; quiz 957. PubMed ID: 23602421 [TBL] [Abstract][Full Text] [Related]
8. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136 [TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Kamat PP; Gupta S; Ensor JE; Murthy R; Ahrar K; Madoff DC; Wallace MJ; Hicks ME Cardiovasc Intervent Radiol; 2008; 31(2):299-307. PubMed ID: 17922160 [TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Clouse ME; Perry L; Stuart K; Stokes KR Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544 [TBL] [Abstract][Full Text] [Related]
11. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443 [TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver. Gaur SK; Friese JL; Sadow CA; Ayyagari R; Binkert CA; Schenker MP; Kulke M; Baum R Cardiovasc Intervent Radiol; 2011 Jun; 34(3):566-72. PubMed ID: 21431978 [TBL] [Abstract][Full Text] [Related]
13. 31P MR spectroscopy to evaluate the efficacy of hepatic artery embolization in the treatment of neuroendocrine liver metastases. Ljungberg M; Westberg G; Vikhoff-Baaz B; Starck G; Wängberg B; Ekholm S; Ahlman H; Forssell-Aronsson E Acta Radiol; 2012 Dec; 53(10):1118-26. PubMed ID: 23051638 [TBL] [Abstract][Full Text] [Related]
14. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. Diamandidou E; Ajani JA; Yang DJ; Chuang VP; Brown CA; Carrasco HC; Lawrence DD; Wallace S AJR Am J Roentgenol; 1998 Feb; 170(2):339-44. PubMed ID: 9456942 [TBL] [Abstract][Full Text] [Related]
15. Hepatic artery embolization for metastatic endocrine-secreting tumors of the pancreas. Report of two cases. Clouse ME; Lee RG; Duszlak EJ; Lokich JJ; Alday MT Gastroenterology; 1983 Nov; 85(5):1183-6. PubMed ID: 6194040 [TBL] [Abstract][Full Text] [Related]
19. Intrahepatic arterial chemoembolization for hepatocellular carcinoma and metastatic neuroendocrine tumors in the era of liver transplantation. Martin M; Tarara D; Wu YM; Ukah F; Fabrega A; Corwin C; Lang E; Mitros F Am Surg; 1996 Sep; 62(9):724-32. PubMed ID: 8751763 [TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]